204 related articles for article (PubMed ID: 35903952)
1. Liquid biopsy: blood-based analyses of circulating cell-free DNA in xenografts.
Heidrich I; Pantel K
EMBO Mol Med; 2022 Aug; 14(8):e16326. PubMed ID: 35903952
[TBL] [Abstract][Full Text] [Related]
2. Liquid biopsy in breast cancer: A comprehensive review.
Alimirzaie S; Bagherzadeh M; Akbari MR
Clin Genet; 2019 Jun; 95(6):643-660. PubMed ID: 30671931
[TBL] [Abstract][Full Text] [Related]
3. Liquid Biopsy in Bladder Cancer.
Cui Y; Cao M
Methods Mol Biol; 2023; 2695():111-120. PubMed ID: 37450114
[TBL] [Abstract][Full Text] [Related]
4. Methods for the Detection of Circulating Biomarkers in Cancer Patients.
Mondelo-Macía P; Rodríguez-Ces AM; Suárez-Cunqueiro MM; Romay LM
Adv Exp Med Biol; 2022; 1379():525-552. PubMed ID: 35761006
[TBL] [Abstract][Full Text] [Related]
5. [Liquid biopsy to indvidualise therapy in advanced bladder cancer].
Junker K
Aktuelle Urol; 2022 Apr; 53(2):180-187. PubMed ID: 34875700
[TBL] [Abstract][Full Text] [Related]
6. Liquid biopsy in colorectal cancer.
Najafi S; Majidpoor J; Mortezaee K
Clin Chim Acta; 2024 Jan; 553():117674. PubMed ID: 38007059
[TBL] [Abstract][Full Text] [Related]
7. Liquid biopsy in mice bearing colorectal carcinoma xenografts: gateways regulating the levels of circulating tumor DNA (ctDNA) and miRNA (ctmiRNA).
Gasparello J; Allegretti M; Tremante E; Fabbri E; Amoreo CA; Romania P; Melucci E; Messana K; Borgatti M; Giacomini P; Gambari R; Finotti A
J Exp Clin Cancer Res; 2018 Jun; 37(1):124. PubMed ID: 29941002
[TBL] [Abstract][Full Text] [Related]
8. The relevance of liquid biopsy in surgical oncology: The application of perioperative circulating nucleic acid dynamics in improving patient outcomes.
Jordan PR; O'Leary DP; Fleming CA; Wang J; Redmond HP
Surgeon; 2022 Aug; 20(4):e163-e173. PubMed ID: 34362650
[TBL] [Abstract][Full Text] [Related]
9. Liquid Biopsy: Current Status and Future Perspectives.
Mader S; Pantel K
Oncol Res Treat; 2017; 40(7-8):404-408. PubMed ID: 28693023
[TBL] [Abstract][Full Text] [Related]
10. The functional and clinical roles of liquid biopsy in patient-derived models.
Zhu Z; Hu E; Shen H; Tan J; Zeng S
J Hematol Oncol; 2023 Apr; 16(1):36. PubMed ID: 37031172
[TBL] [Abstract][Full Text] [Related]
11. The potential of liquid biopsies in gastrointestinal cancer.
Wu C; Zhang J; Li H; Xu W; Zhang X
Clin Biochem; 2020 Oct; 84():1-12. PubMed ID: 32540214
[TBL] [Abstract][Full Text] [Related]
12. Liquid Biopsy beyond Circulating Tumor Cells and Cell-Free DNA.
Junqueira-Neto S; Batista IA; Costa JL; Melo SA
Acta Cytol; 2019; 63(6):479-488. PubMed ID: 30783027
[TBL] [Abstract][Full Text] [Related]
13. Liquid biopsy in CNS tumors: Current status & future perspectives.
Husain N; Husain A; Mishra S; Srivastava P
Indian J Pathol Microbiol; 2022 May; 65(Supplement):S111-S121. PubMed ID: 35562141
[TBL] [Abstract][Full Text] [Related]
14. Liquid biopsy and their application progress in head and neck cancer: focus on biomarkers CTCs, cfDNA, ctDNA and EVs.
Meng Y; Bian L; Zhang M; Bo F; Lu X; Li D
Biomark Med; 2020 Oct; 14(14):1393-1404. PubMed ID: 33073579
[TBL] [Abstract][Full Text] [Related]
15. The Different Facets of Liquid Biopsy: A Kaleidoscopic View.
Eslami-S Z; Cortés-Hernández LE; Cayrefourcq L; Alix-Panabières C
Cold Spring Harb Perspect Med; 2020 Jun; 10(6):. PubMed ID: 31548226
[TBL] [Abstract][Full Text] [Related]
16. Novel Markers for Liquid Biopsies in Cancer Management: Circulating Platelets and Extracellular Vesicles.
Corvigno S; Johnson AM; Wong KK; Cho MS; Afshar-Kharghan V; Menter DG; Sood AK
Mol Cancer Ther; 2022 Jul; 21(7):1067-1075. PubMed ID: 35545008
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal monitoring of disease burden and response using ctDNA from dried blood spots in xenograft models.
Sauer CM; Heider K; Belic J; Boyle SE; Hall JA; Couturier DL; An A; Vijayaraghavan A; Reinius MA; Hosking K; Vias M; Rosenfeld N; Brenton JD
EMBO Mol Med; 2022 Aug; 14(8):e15729. PubMed ID: 35694774
[TBL] [Abstract][Full Text] [Related]
18. Liquid Biopsy, the hype vs. hope in molecular and clinical oncology.
Mohanty A; Mohanty SK; Rout S; Pani C
Semin Oncol; 2021 Jun; 48(3):259-267. PubMed ID: 34384614
[TBL] [Abstract][Full Text] [Related]
19. Circulating cell-free tumor DNA analysis in pediatric cancers.
Andersson D; Fagman H; Dalin MG; Ståhlberg A
Mol Aspects Med; 2020 Apr; 72():100819. PubMed ID: 31563277
[TBL] [Abstract][Full Text] [Related]
20. Cell Free DNA as an Evolving Liquid Biopsy Biomarker for Initial Diagnosis and Therapeutic Nursing in Cancer- An Evolving Aspect in Medical Biotechnology.
Ray SK; Mukherjee S
Curr Pharm Biotechnol; 2022; 23(1):112-122. PubMed ID: 33308128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]